CanSinoBIO ConSino Bio specializes in the development and production of high-qua
With a registered capital of RMB 156 million, ConSinoBio is a national high-tech enterprise founded by the senior management team of a multinational pharmaceutical company. With the mission of providing solutions for the prevention of infectious diseases and infectious diseases worldwide, ConSino Bio specializes in the development and production of high-quality human vaccines.
Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
Business community: the fundamentals have improved, and PTA may remain upward
The new development bank issued 7 billion yuan of Panda Bonds for infrastructure projects in member countries
361 degrees announced that the retail sales of main brand products in the first quarter recorded a high double-digit growth year-on-year.
2022 China AI Health 30 Report
Sun paper: the subsidiary plans to acquire 100% equity of Liujing Chengquan with 1.5 billion yuan
The communication service sector opened stronger
A fire broke out in a mechanical and electrical plant in Huaiyuan, Anhui Province, and local fire and public security departments are rescuing
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
Great Wall Motor Performance express: in 2021, the net profit was 6.782 billion yuan, a year-on-year increase of 26.47%.
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
The revised version of the detailed rules of the standards for the audit of network short video content was released
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
Gem new shares continue to strengthen, and N Huayan is temporarily suspended
Yuan universe concept stocks rose and warmed up, and shuobaid rose more than 8%
Hong Kong Pharmaceutical stocks continued to decline, and Qiming medical fell more than 14%
Qin Lihong, President of Weilai: we will not launch flying cars, which is not on our reasonable strategic expansion route